These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34614012)

  • 21. Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and Tanzania.
    Ammerdorffer A; Rushwan S; Timms R; Wright P; Beeson L; Devall AJ; Mammoliti KM; Alwy Al-Beity FM; Galadanci H; Hofmeyr GJ; Singata-Madliki M; Qureshi Z; Lambert P; Gallos ID; Coomarasamy A; Gülmezoglu AM
    Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):46-55. PubMed ID: 35762808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quality of care to prevent and treat postpartum hemorrhage and pre-eclampsia/eclampsia : an observational assessment in Madagascar's hospitals].
    Bazant E; Rakotovao JP; Rasolofomanana JR; Tripathi V; Gomez P; Favero R; Moffson S
    Med Sante Trop; 2013 May; 23(2):168-75. PubMed ID: 23694783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject™ by peripheral health care providers at home births: design of a community-based cluster-randomized trial.
    Stanton CK; Newton S; Mullany LC; Cofie P; Agyemang CT; Adiibokah E; Darcy N; Khan S; Levisay A; Gyapong J; Armbruster D; Owusu-Agyei S
    BMC Pregnancy Childbirth; 2012 Jun; 12():42. PubMed ID: 22676921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
    Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
    Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
    Musa AO; Ijaiya MA; Saidu R; Aboyeji AP; Jimoh AA; Adesina KT; Abdul IF
    Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge, attitudes, and practices related to uterotonic drugs during childbirth in Karnataka, India: a qualitative research study.
    Deepak NN; Mirzabagi E; Koski A; Tripathi V
    PLoS One; 2013; 8(4):e62801. PubMed ID: 23638148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR).
    Sentilhes L; Vayssière C; Deneux-Tharaux C; Aya AG; Bayoumeu F; Bonnet MP; Djoudi R; Dolley P; Dreyfus M; Ducroux-Schouwey C; Dupont C; François A; Gallot D; Haumonté JB; Huissoud C; Kayem G; Keita H; Langer B; Mignon A; Morel O; Parant O; Pelage JP; Phan E; Rossignol M; Tessier V; Mercier FJ; Goffinet F
    Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():12-21. PubMed ID: 26773243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Misoprostol: off-label use in the treatment of post-partum hemorrhage].
    Garrigue A; Pierre F
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):179-89. PubMed ID: 24457021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness and use of tranexamic acid in the management of postpartum hemorrhage among health care professionals in Enugu, Nigeria.
    Onwujekwe O; Mosanya AU; Ekwuazi K; Iyoke C
    Int J Gynaecol Obstet; 2024 Feb; 164(2):668-676. PubMed ID: 37814923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings.
    Carvalho N; Hoque ME; Oliver VL; Byrne A; Kermode M; Lambert P; McIntosh MP; Morgan A
    BMC Med; 2020 Jul; 18(1):201. PubMed ID: 32718336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
    Westhoff G; Cotter AM; Tolosa JE
    Cochrane Database Syst Rev; 2013 Oct; (10):CD001808. PubMed ID: 24173606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in obstetric practices and outcomes of postpartum hemorrhage across Nigerian health facilities.
    Wakili AA; Aswat A; Timms R; Beeson L; Mammoliti KM; Devall A; Musa BM; Amole T; Dankishiya F; Coomarasamy A; Gallos ID; Galadanci HS
    Int J Gynaecol Obstet; 2022 Jun; 158 Suppl 1(Suppl 1):23-30. PubMed ID: 35762807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to optimal and appropriate use of uterotonics during active labour and for prevention of postpartum haemorrhage in public health care facilities: An exploratory study in five states of India.
    Singh S; Chandhiok N; Dubey R; Goel R; Kashyap J
    Sex Reprod Healthc; 2021 Sep; 29():100624. PubMed ID: 33964587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers inhibiting effective detection and management of postpartum hemorrhage during facility-based births in Madagascar: findings from a qualitative study using a behavioral science lens.
    Flanagan SV; Razafinamanana T; Warren C; Smith J
    BMC Pregnancy Childbirth; 2021 Apr; 21(1):320. PubMed ID: 33888075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects and side effects of misoprostol and oxytocin in the postpartum period: A systematic review.
    Bilgin Z; Kömürcü N
    Taiwan J Obstet Gynecol; 2019 Nov; 58(6):748-756. PubMed ID: 31759522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of care in prevention, detection and management of postpartum hemorrhage in hospitals in Afghanistan: an observational assessment.
    Ansari N; Maruf F; Manalai P; Currie S; Soroush MS; Amin SS; Higgins-Steele A; Kim YM; Stekelenburg J; van Roosmalen J; Tappis H
    BMC Health Serv Res; 2020 Jun; 20(1):484. PubMed ID: 32487154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
    Al-Sawaf A; El-Mazny A; Shohayeb A
    J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial.
    Stanton CK; Newton S; Mullany LC; Cofie P; Tawiah Agyemang C; Adiibokah E; Amenga-Etego S; Darcy N; Khan S; Armbruster D; Gyapong J; Owusu-Agyei S
    PLoS Med; 2013 Oct; 10(10):e1001524. PubMed ID: 24130463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
    Ugwu IA; Oluwasola TA; Enabor OO; Anayochukwu-Ugwu NN; Adeyemi AB; Olayemi OO
    Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial.
    Alalfy M; Lasheen Y; Elshenoufy H; Elzahaby IM; Kaleem HW; El Sawah H; Azkalani A; Saber W; Rashwan ASSA
    J Matern Fetal Neonatal Med; 2020 May; 33(9):1459-1465. PubMed ID: 30176758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.